NASH-TAG 2021 co-director Vlad Ratziu and Global Liver Institute President/CEO Donna Cryer join the Surfers to review high points of the conference.

The discussion ranges from the reasons that NASH-TAG is so special to the implications of increasing disease knowledge.

Along the way, the group pays significant attention to the growing knowledge about non-invasive clinical testing, the value that an array of drugs with different modes of action are proceeding toward clinical success and eventually treatment of large numbers of patients.

In addition to adding to the substantive conversation, co-directors Vlad Ratziu and Stephen Harrison discuss how specific elements of conference design lend to integrated thinking and thoughtful analysis of complex phenomena.

This is a fitting wrap-up for a fantastic conference.